Cannabidiol reduces ethanol consumption, motivation and relapse in mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works by García-Gutiérrez, María S.
Results: 18
1
2
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
Gender differences in the effects of cannabidiol on ethanol binge drinking in mice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
4
Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 12, p. 2515, doi. 10.1038/npp.2013.157
- By:
- Publication type:
- Article
5
Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB<sub>2</sub> Receptors.
- Published in:
- Neuropsychopharmacology, 2012, v. 37, n. 7, p. 1749, doi. 10.1038/npp.2012.22
- By:
- Publication type:
- Article
6
Association of cannabinoid receptor genes ( ) polymorphisms and panic disorder.
- Published in:
- 2020
- By:
- Publication type:
- journal article
7
Increased vulnerability to ethanol consumption in adolescent maternal separated mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
8
Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress.
- Published in:
- 2018
- By:
- Publication type:
- journal article
9
Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 1, p. 105, doi. 10.1177/0269881109358204
- By:
- Publication type:
- Article
10
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 1, p. 111, doi. 10.1177/0269881110379507
- By:
- Publication type:
- Article
11
The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines.
- Published in:
- Journal of Psychopharmacology, 2010, v. 24, n. 5, p. 757, doi. 10.1177/0269881109106910
- By:
- Publication type:
- Article
12
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6268, doi. 10.3390/ijms25116268
- By:
- Publication type:
- Article
13
Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
14
Chronic blockade of cannabinoid CB<sub>2</sub> receptors induces anxiolytic-like actions associated with alterations in GABA<sub>A</sub> receptors.
- Published in:
- British Journal of Pharmacology, 2012, v. 165, n. 4, p. 951, doi. 10.1111/j.1476-5381.2011.01625.x
- By:
- Publication type:
- Article
15
Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142978
- By:
- Publication type:
- Article
16
Biomarkers of the Endocannabinoid System in Substance Use Disorders.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 3, p. 396, doi. 10.3390/biom12030396
- By:
- Publication type:
- Article
17
CB2 Receptor Involvement in the Treatment of Substance Use Disorders.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 11, p. 1556, doi. 10.3390/biom11111556
- By:
- Publication type:
- Article
18
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 11, p. 1575, doi. 10.3390/biom10111575
- By:
- Publication type:
- Article